Baseline Quality Improvement Capacity of 33 Endocrinology Centers Participating in the T1D Exchange Quality Improvement Collaborative
Author(s) -
Brynn E. Marks,
Ann Mungmode,
Aneyman,
Laura E. Levin,
Nicole Rioles,
Donna Eng,
Joyce M. Lee,
Marina Basina,
Nana Hawah-Jones,
Elizabeth A. Mann,
Grenye O’Malley,
Meredith Wilkes,
Devin Steenkamp,
Grazia Aleppo,
Siham Accacha,
Osagie Ebekozien
Publication year - 2022
Publication title -
clinical diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.931
H-Index - 37
eISSN - 1945-4953
pISSN - 0891-8929
DOI - 10.2337/cd22-0071
Subject(s) - medicine , benchmarking , quality management , baseline (sea) , type 2 diabetes , quality (philosophy) , health care , medical education , family medicine , diabetes mellitus , operations management , marketing , endocrinology , business , engineering , management system , philosophy , oceanography , epistemology , economic growth , economics , geology
This article describes the evolution of the Type 1 Diabetes Exchange Quality Improvement Collaborative (T1DX-QI) and provides insight into the development and growth of a successful type 1 diabetes quality improvement (QI) program. Since its inception 8 years ago, the collaborative has expanded to include centers across the United States with varying levels of QI experience, while simultaneously achieving many tangible improvements in type 1 diabetes care. These successes underscore the importance of learning health systems, data-sharing, benchmarking, and peer collaboration as drivers for continuous QI. Future efforts will include recruiting additional small- to medium-sized centers focused on adult care and underserved communities to further the goal of improving care and outcomes for all people living with type 1 diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom